Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1993-10-05
1997-11-25
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
435 693, 4351723, A61K 3915
Patent
active
056909381
ABSTRACT:
Method of inducing a mucosal and or/systemic immune response in a host, comprising the step of administering to the host an effective amount of a Bluetongue antigen in the form of virus like and/or virus core like particles. Vaccines are also provided.
REFERENCES:
Holmgren, FEMS Microbiology Immunology vol. 89, pp. 1-10, "Mucosal immunity and vaccination", 1991.
French, T.J et al. J. Virol. 64(4): 1530-36, 1990.
Lycke, N. et al. Immunology 59:301-308, 1986.
Boslego, J.W. et al. "Gonorrhea Vaccines" In: Vaccines and Immunotherapy S.J. Gruz Ed., Pergamon Press, 1991.
Ellis, R.W. "New Technologies for Making Vaccines", In: Vaccines, Plotkin & Mortimer Eds., W.B. Saunders Co. 1988.
French, T.J. et al. J. Virol. 64(12):5695-5700, 1990.
Huismans, H et al. Virology 157: 180-188, 1987.
Ermak Thomas H.
Guirakhoo Farshad
Monath Thomas P.
Nichols, Jr. Richard D.
Pappo Jacques
Natural Environment Research Council
Nucker Christine M.
OraVax, Inc.
LandOfFree
Oral immunization with multiple particulate antigen delivery sys does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral immunization with multiple particulate antigen delivery sys, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral immunization with multiple particulate antigen delivery sys will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2104459